Therapy News and Research

RSS

Did people use mental health services more during the COVID-19 pandemic?

Researchers explored the utilization rates of mental health services among adults during the coronavirus disease 2019 (COVID-19) pandemic.

11 Jan 2023

Simple method increases the efficacy of T cell therapy by cytokine conjugation

The recent years have seen a wave of adoptive cell therapies (ACTs), a type of immunotherapy in which T cells (T cell transfer therapy) and other immune cells are obtained from patients, activated and multiplied outside the body, and infused in larger numbers back into the blood circulation to help fight cancers.

11 Jan 2023

Review shows metformin usage to be associated with better COVID-19 outcomes

Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.

11 Jan 2023

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in The Journal of Urology, an Official Journal of the American Urological Association.

11 Jan 2023

Neurosurgeons discover potential markers of glial brain tumors

RUDN University neurosurgeons have discovered potential markers of the most common brain tumor. They turned out to be microRNAs - small sequences of nucleotides.

11 Jan 2023

FUJIFILM Irvine Scientific launches HEK293 Feed, specifically designed for viral vector production

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the launch of its BalanCD HEK293 Viral Feed.

11 Jan 2023

RNAs may be a promising biomarker and therapeutic target for ischemic stroke

RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke.

10 Jan 2023

Performing acts of kindness may help people suffering from depression or anxiety

People suffering from symptoms of depression or anxiety may help heal themselves by doing good deeds for others, new research shows.

10 Jan 2023

New method can predict cancer patients' survival within hours after chemotherapy

Researchers from the University of Bergen, Norway, has found a new method that within hours can predict if certain cancer patients will survive or not after chemotherapy.

10 Jan 2023

MIS-C more common and severe than previously thought

In a recent study published in the JAMA Network Open journal, researchers compared the characteristics of multisystem inflammatory syndrome in children (MIS-C) and coronavirus disease 2019 (COVID-19).

10 Jan 2023

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Immunotherapy is a way of treating cancer by reprogramming the patient's immune system to attack their tumor.

10 Jan 2023

West Health and Sharp Memorial Hospital join forces to create a new integrated geriatric care model

Through a three-year partnership that seeks to enhance the healthcare journey of older adults, West Health and Sharp Memorial Hospital will work together to create a new integrated geriatric care model spanning the entire health care continuum, from the emergency department and operating room to primary care.

10 Jan 2023

Researchers demonstrate the role of Klotho protein in the formation of osteoarthritis

Researchers in the United States and Japan have discovered a new mechanism that links age-related cartilage tissue stiffening with the repression of a key protein associated with longevity.

10 Jan 2023

Researchers review bacteriophage treatment

Researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy.

10 Jan 2023

Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and scalable processes for gene delivery

Collaboration set to develop and implement high-throughput analytical methods in support of Vector BioPharma’s CMC (chemistry, manufacturing and controls) development.

From Vector BioPharma 10 Jan 2023

Therapy News and Research

Did people use mental health services more during the COVID-19 pandemic?

Simple method increases the efficacy of T cell therapy by cytokine conjugation

Review shows metformin usage to be associated with better COVID-19 outcomes

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

Neurosurgeons discover potential markers of glial brain tumors

FUJIFILM Irvine Scientific launches HEK293 Feed, specifically designed for viral vector production

RNAs may be a promising biomarker and therapeutic target for ischemic stroke

Performing acts of kindness may help people suffering from depression or anxiety

New method can predict cancer patients' survival within hours after chemotherapy

MIS-C more common and severe than previously thought

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

West Health and Sharp Memorial Hospital join forces to create a new integrated geriatric care model

Researchers demonstrate the role of Klotho protein in the formation of osteoarthritis

Researchers review bacteriophage treatment

Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and scalable processes for gene delivery

Behavioral telehealth loses momentum without a regulatory boost

Vaccinating against toxin produced by E. coli may protect against malnutrition and stunting

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

Detailed molecular profile of endometriosis can lead to improved care for millions of women

Understanding the molecular basis of how THC cannabinoid inhibits an important human enzyme

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News